Literature DB >> 22574475

Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran.

K Samimi-Rad1, M Hosseini, G Mobeini, F Asgari, S M Alavian, M E Tahaei, H Salari.   

Abstract

A cross-sectional study was made of the prevalence of HCV and associated risk factors in 382 multi-transfused patients and haemodialysis staff in Yadz province in 2006. Of those tested for anti-HCV antibodies, 50.6% of patients with inherited bleeding disorders, 11.8% with thalassaemia and 5.0% undergoing haemodialysis were seropositive. First transfusion before 1996 (when blood donor screening started) was the common risk factor associated with HCV infection. Only 1/52 haemodialysis staff members was HCV infected (an intravenous drug user). Infection control measures were poor in all centres. In patients with inherited bleeding disorders genotype 1 (65.0%) was the predominant followed by genotype 3 (35.0%). The results provide evidence that blood donor screening and use of virus-inactivated factor concentrates have lowered the risk of HCV infection among multi-transfused patients.

Entities:  

Mesh:

Year:  2012        PMID: 22574475     DOI: 10.26719/2012.18.3.227

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  8 in total

Review 1.  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Authors:  Soheil Ashkani-Esfahani; Seyed Moayed Alavian; Mohammad Salehi-Marzijarani
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

2.  An unbelievable fact on "dialysis centers without hepatitis C infection".

Authors:  Seyed Moayed Alavian
Journal:  Nephrourol Mon       Date:  2014-03-01

Review 3.  Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.

Authors:  Nahid Ramezan Ghorbani; Shirin Djalalinia; Mitra Modirian; Zahra Esmaeili Abdar; Morteza Mansourian; Armita Mahdavi Gorabi; Hamid Asayesh; Hossein Ansari; Mehrdad Kazemzadeh Atoofi; Ramin Tajbakhsh; Mehdi Noroozi; Saeid Safiri; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2017-11-28       Impact factor: 1.852

4.  Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.

Authors:  Paul Henriot; Mathieu Castry; Liem Binh Luong Nguyen; Yusuke Shimakawa; Kévin Jean; Laura Temime
Journal:  Aliment Pharmacol Ther       Date:  2022-06-27       Impact factor: 9.524

5.  Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral Strains.

Authors:  Katayoun Samimi-Rad; Freshteh Asgari; Mohsen Nasiritoosi; Abdoulreza Esteghamati; Azar Azarkeyvan; Seyedeh Masoomeh Eslami; Farhad Zamani; Lars Magnius; Seyed Moayed Alavian; Heléne Norder
Journal:  Hepat Mon       Date:  2013-01-23       Impact factor: 0.660

6.  Evaluation of antibody frequency against HBV, HCV and HTLV-1.

Authors:  Seyed Mohammad Ebrahim Tahaei; Seyed Reza Mohebbi; Seyed Reza Fatemi; Pedram Azimzadeh; Dariush Mirsattari; Azar Sanati; Afsaneh Sharifian
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012

7.  Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran.

Authors:  Katayoun Samimi-Rad; Ramin Rahimnia; Mahdi Sadeghi; Seyed Amir Malekpour; Mona Marzban; Maryam Keshvari; Seyed Jalal Kiani; Seyed-Moayed Alavian
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

Review 8.  The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Hossein Ghaderi-Zefrehi; Mohammad Gholami-Fesharaki; Heidar Sharafi; Farzin Sadeghi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-08-23       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.